Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...
Rhythm Pharmaceuticals' Imcivree shows promise in treating obesity from brain damage, reducing BMI by 16.5% in Phase 3 trial; ...